Kaleido Biosciences Inc (KLDO)


Stock Price Forecast

April 14, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Kaleido Biosciences Inc chart...

About the Company

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the gut's existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.

Exchange

NASDAQ

Website

kaleido.com

$1M

Total Revenue

82

Employees

$12M

Market Capitalization

-0.13

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $KLDO News

Kaleido Biosciences Inc KLDO

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Kaleido Biosciences (OTC: KLDO)

5d ago, source: The Motley Fool

Kaleido Biosciences, Inc. is a clinical-stage healthcare company, which engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve ...

Flagship Ventures Fund 2007, L.P.'s Net Worth

6d ago, source: Benzinga.com

Who is Flagship Ventures Fund 2007, L.P.? Flagship Ventures Fund 2007, L.P. has an estimated net worth of $280 Million. This is based on reported shares across multiple companies, which include ...

Flagship Ventures 2007 General Partner LLC's Net Worth

6d ago, source: Benzinga.com

Who is Flagship Ventures 2007 General Partner LLC? Flagship Ventures 2007 General Partner LLC has an estimated net worth of $280 Million. This is based on reported shares across multiple companies ...

Kaleido Japan Inc.

3mon ago, source: Statista

Kaleido Japan Inc. was founded in 2011 and operates in Tokyo, Japan. The company engages in the sector 'Construction' (ISIC: F). The construction industry, which can be divided into several ...

Pacira BioSciences Inc.

4d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Castle Biosciences, Inc. (NASDAQ:CSTL): Are Analysts Optimistic?

18d ago, source: Yahoo Finance

With the business potentially at an important milestone, we thought we'd take a closer look at Castle Biosciences, Inc.'s (NASDAQ:CSTL) future prospects. Castle Biosciences, Inc., a commercial ...

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates

19d ago, source: Nasdaq

Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $0.78 per share a year ago.

CTKB Cytek Biosciences, Inc.

3d ago, source: Seeking Alpha

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and ...

Kaleido Biosciences, Inc. (KLDO)

1mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...